4-Bromo-5-methyl-3-phenylisoxazole → 1-Isopropylsulfonyl-2-amino-6-(3-phenyl-5-methylisoxazol-4-yl)benzimidazole
Reaktionsgleichung
[C:1]1([C:7]2[C:11](Br)=[C:10]([CH3:13])[O:9][N:8]=2)[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.[CH:14]([S:17]([N:20]1[C:24]2[CH:25]=[C:26](B(O)O)[CH:27]=[CH:28][C:23]=2[N:22]=[C:21]1[NH2:32])(=[O:19])=[O:18])([CH3:16])[CH3:15]>>[CH:14]([S:17]([N:20]1[C:24]2[CH:25]=[C:26]([C:11]3[C:7]([C:1]4[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=4)=[N:8][O:9][C:10]=3[CH3:13])[CH:27]=[CH:28][C:23]=2[N:22]=[C:21]1[NH2:32])(=[O:18])=[O:19])([CH3:16])[CH3:15]Komponenten
3
Versuchsvorschrift
Beginning with 3-phenyl-4-bromo-5-methylisoxazole and 1-isopropylsulfonyl-2-aminobenzimidazole-6-boronic acid, the title compound may be prepared essentially as described in EXAMPLE 59.
Quellen und Nachweise
- ORD-Eintrag
- ord-831659b2fee04d66b9f77b6a60d549da
- Quelldatensatz
- uspto-grants-2011_01